Elevated serum Raftlin levels in non-muscle invasive bladder cancer: diagnostic implications and rs690037 genotype analysis.

Balci S, Tanriverdi R, Nebioğlu A, Yildirim DD, Gülüm C, Bozlu M, Tamer L.

DOI: 10.1590/1806-9282.20251628
Published: 2026-06-15
Container: Rev Assoc Med Bras (1992)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1590/1806-9282.20251628,
  title = {Elevated serum Raftlin levels in non-muscle invasive bladder cancer: diagnostic implications and rs690037 genotype analysis.},
  author = {Balci S and  Tanriverdi R and  Nebioğlu A and  Yildirim DD and  Gülüm C and  Bozlu M and  Tamer L.},
  year = {2026},
  journal = {Rev Assoc Med Bras (1992)},
  doi = {10.1590/1806-9282.20251628},
  url = {https://doi.org/10.1590/1806-9282.20251628}
}

RIS

TY  - JOUR
TI  - Elevated serum Raftlin levels in non-muscle invasive bladder cancer: diagnostic implications and rs690037 genotype analysis.
AU  - Balci S
AU  -  Tanriverdi R
AU  -  Nebioğlu A
AU  -  Yildirim DD
AU  -  Gülüm C
AU  -  Bozlu M
AU  -  Tamer L.
PY  - 2026
JO  - Rev Assoc Med Bras (1992)
DO  - 10.1590/1806-9282.20251628
UR  - https://doi.org/10.1590/1806-9282.20251628
ER  -

APA

S, B., R, T., A, N., DD, Y., C, G., M, B., & L., T. (2026). Elevated serum Raftlin levels in non-muscle invasive bladder cancer: diagnostic implications and rs690037 genotype analysis.. Rev Assoc Med Bras (1992). https://doi.org/10.1590/1806-9282.20251628

Source records

europe-pmc · retrieved 2026-09-26T09:21:21.897Z